LAB Price / Book | Standard BioTools Inc.

STANDARD BIOTOOLS INC. Price/Book Ratio

The price-to-book (P/B) ratio compares what the stock market says a company is worth with what the company's own books say it is worth. It is market capitalization divided by shareholder equity, the book value left after subtracting liabilities from assets, and the table shows both amounts. A ratio of 1.0 means market value equals book value; a higher ratio means investors value the company above its net assets, often for brands, software or expected growth the books do not record. A negative ratio means equity is negative. Each point uses the filed share count and the last closing price on or before the equity's reporting date, never today's price.

STANDARD BIOTOOLS INC. price/book ratio for the quarter ending 2026-06-30 was 0.6, a 44.14% decline year-over-year.
STANDARD BIOTOOLS INC. price/book ratio for the quarter ending 2026-03-31 was 0.64, a 28.80% decline year-over-year.
STANDARD BIOTOOLS INC. price/book ratio for the quarter ending 2025-12-31 was 1.16, a 17.42% decline year-over-year.
STANDARD BIOTOOLS INC. price/book ratio for the quarter ending 2025-09-30 was 1.25, a 15.01% decline year-over-year.
STANDARD BIOTOOLS INC. price/book ratio for fiscal 2026 was 0.6.
STANDARD BIOTOOLS INC. price/book ratio for fiscal 2025 was 1.16, a 17.42% decline from fiscal 2024.
STANDARD BIOTOOLS INC. price/book ratio for fiscal 2024 was 1.4, a change of 2.6 from fiscal 2023.
STANDARD BIOTOOLS INC. price/book ratio for fiscal 2023 was -1.2, a change of -0.06 from fiscal 2022.

Available history: 2011-06-30 to 2026-06-30
Data captured: 2026-06-30

Historical Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-06-30	0.6	$322.72M	$539.97M
2026-03-31	0.64	$359.83M	$561.12M
2025-12-31	1.16	$490.7M	$424.29M
2025-09-30	1.25	$498.7M	$399.66M
2025-06-30	1.07	$454.21M	$424.54M
2025-03-31	0.9	$409.41M	$454.6M
2024-12-31	1.4	$660.68M	$471.72M
2024-09-30	1.47	$718.46M	$489.33M
2024-06-30	1.29	$656.89M	$510.26M
2024-03-31	1.79	$1.03B	$577.32M
2023-12-31	-1.2	$177.31M	-$148.05M
2023-09-30	-1.75	$230.46M	-$131.72M
2023-06-30	-1.35	$152.7M	-$113.39M
2023-03-31	-1.58	$153.37M	-$97.15M
2022-12-31	-1.14	$92.99M	-$81.47M
2022-09-30	-1.39	$87.17M	-$62.75M
2022-06-30	-3.36	$125.85M	-$37.45M
2022-03-31	12.53	$277.14M	$22.11M
2021-12-31	3.19	$301.52M	$94.6M
2021-09-30	5.07	$504.04M	$99.34M
2021-06-30	4.29	$469.18M	$109.45M
2021-03-31	2.76	$338.83M	$122.94M
2020-12-31	3.22	$447.26M	$139.05M
2020-09-30	3.62	$550.67M	$151.97M
2020-06-30	2.15	$285.84M	$132.72M
2020-03-31	1.27	$179.57M	$141.5M
2019-12-31	1.58	$243.45M	$153.61M
2019-09-30	1.98	$322.02M	$162.61M
2019-06-30	4.95	$855.01M	$172.64M
2019-03-31	5.03	$916.89M	$182.25M
2018-12-31	5.9	$425.29M	$72.12M
2018-09-30	13.14	$294.48M	$22.41M
2018-06-30	6.7	$233.36M	$34.83M
2018-03-31	4.68	$227.22M	$48.57M
2018-01-01	7.3	$228.46M	$31.29M
2017-12-31	7.39	$228.46M	$30.94M
2017-09-30	4.98	$194.65M	$39.07M
2017-06-30	4.96	$118.84M	$23.94M
2017-03-31	4.33	$166.67M	$38.5M
2016-12-31	3.99	$212.63M	$53.23M
2016-09-30	3.43	$233.24M	$67.97M
2016-06-30	3.11	$262.2M	$84.26M
2016-03-31	2.36	$233.19M	$98.98M
2015-12-31	2.71	$311.8M	$114.9M
2015-09-30	1.88	$233.45M	$124.13M
2015-06-30	5.25	$698.9M	$133.22M
2015-03-31	8.49	$1.21B	$142.45M
2014-12-31	6.36	$955.94M	$150.42M
2014-09-30	4.48	$691.78M	$154.56M
2014-06-30	5.12	$827.87M	$161.83M
2014-03-31	7.37	$1.23B	$167.43M
2013-12-31	10.25	$988.05M	$96.41M
2013-09-30	5.79	$561.47M	$97.01M
2013-06-30	4.52	$444.86M	$98.39M
2013-03-31	4.7	$470.14M	$100.12M
2012-12-31	3.57	$359.4M	$100.66M
2012-09-30	4.14	$424.8M	$102.66M
2012-06-30	6.34	$310.32M	$48.92M
2012-03-31	6.21	$322.4M	$51.9M
2011-12-31	4.7	$267.42M	$56.9M
2011-09-30	4.76	$281.83M	$59.15M
2011-06-30	5.38	$335.17M	$62.31M

Annual Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-06-30	0.6	$322.72M	$539.97M
2025-12-31	1.16	$490.7M	$424.29M
2024-12-31	1.4	$660.68M	$471.72M
2023-12-31	-1.2	$177.31M	-$148.05M
2022-12-31	-1.14	$92.99M	-$81.47M
2021-12-31	3.19	$301.52M	$94.6M
2020-12-31	3.22	$447.26M	$139.05M
2019-12-31	1.58	$243.45M	$153.61M
2018-12-31	5.9	$425.29M	$72.12M
2017-12-31	7.39	$228.46M	$30.94M
2016-12-31	3.99	$212.63M	$53.23M
2015-12-31	2.71	$311.8M	$114.9M
2014-12-31	6.36	$955.94M	$150.42M
2013-12-31	10.25	$988.05M	$96.41M
2012-12-31	3.57	$359.4M	$100.66M
2011-12-31	4.7	$267.42M	$56.9M

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
ROCKET PHARMACEUTICALS, INC. (RCKT)	United States	$0.296B	-21.78
Vanda Pharmaceuticals Inc. (VNDA)	United States	$0.302B	-1.35
Fulcrum Therapeutics, Inc. (FULC)	United States	$0.289B	-3.28
Contineum Therapeutics, Inc. (CTNM)	United States	$0.289B	-4.40
GT Biopharma, Inc. (GTBP)	United States	$0.309B	-4.58
Perspective Therapeutics, Inc. (CATX)	United States	$0.284B	-3.34
Upstream Bio, Inc. (UPB)	United States	$0.284B	-2.42
ABEONA THERAPEUTICS INC. (ABEO)	United States	$0.312B	-5.63
Sagimet Biosciences Inc. (SGMT)	United States	$0.279B
Prelude Therapeutics Inc (PRLD)	United States	$0.318B	-7.01